Do you replace albumin in cases of hypoalbuminemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Albumin Replacement in Hypoalbuminemia

Albumin replacement is not recommended for patients with hypoalbuminemia (serum albumin of 1.2 g/dL) unless specific clinical indications are present. 1

Evidence-Based Recommendations for Albumin Use

General Principle

  • Intravenous albumin should not be used solely to correct low serum albumin levels or for nutritional purposes 2
  • Hypoalbuminemia is a marker of illness severity rather than a condition requiring direct treatment with albumin infusions 3

Specific Clinical Scenarios Where Albumin IS Indicated

  1. Liver Disease Complications

    • Spontaneous bacterial peritonitis (SBP): Albumin (1.5 g/kg at diagnosis and 1g/kg on day 3) decreases hepatorenal syndrome incidence and improves survival 1
    • Large-volume paracentesis (>5L): Albumin is suggested to prevent paracentesis-induced circulatory dysfunction 1
    • Hepatorenal syndrome: Strong recommendation for albumin administration 2
  2. Fluid Replacement in Specific Conditions

    • Plasmapheresis: Moderate to high quality evidence supports albumin use 2
    • Patients with cirrhosis and SBP with baseline serum bilirubin ≥68 μmol/L or serum creatinine ≥88 μmol/L 1

Clinical Scenarios Where Albumin is NOT Indicated

  1. Critical Care Settings

    • In critically ill adult patients, albumin is not suggested for first-line volume replacement or to increase serum albumin levels 1
    • No mortality benefit found when comparing crystalloid to albumin in critical care 1
  2. Kidney Disease

    • In patients undergoing kidney replacement therapy, albumin is not suggested for prevention or treatment of intradialytic hypotension 1
    • Serum albumin is a valid measure of protein-energy nutritional status in maintenance dialysis patients, but low levels should prompt evaluation for malnutrition rather than albumin replacement 1
  3. Other Conditions

    • Not recommended for removal of extravascular fluid when used with diuretics 1
    • Not recommended in critically ill patients with thermal injuries or ARDS 1

Understanding Hypoalbuminemia

Causes

  • Inflammation reduces albumin synthesis and increases catabolism 3
  • Inadequate protein and caloric intake reduces synthesis 3
  • In kidney disease, albumin loss into dialysate may contribute to hypoalbuminemia 4
  • Hypoalbuminemia in heart failure is associated with increased mortality but not treated with albumin infusions 5

Clinical Significance

  • Hypoalbuminemia is an independent risk factor for adverse outcomes across many disease states 4
  • In maintenance hemodialysis, approximately 60% of patients have albumin concentrations <4.0 g/dL 4
  • Low albumin predicts mortality in chronic kidney disease and heart failure 3, 5

Special Considerations

Pediatric Patients with Congenital Nephrotic Syndrome

  • Some centers administer albumin only when clinically indicated, while others use regular infusion protocols (1-4 g/kg/day) 1
  • Albumin infusions should be based on clinical indicators of hypovolemia rather than serum albumin levels 1
  • Symptoms suggesting hypovolemia include prolonged capillary refill time, tachycardia, hypotension, oliguria, and abdominal discomfort 1

Monitoring Recommendations

  • In dialysis patients, predialysis or stabilized serum albumin is a valid measure of protein-energy nutritional status 1
  • Target albumin level equal to or greater than the lower limit of normal range (approximately 4.0 g/dL for bromcresol green method) 1
  • Low albumin should prompt evaluation for protein-energy malnutrition rather than direct albumin replacement 1

Common Pitfalls to Avoid

  • Treating the number instead of the patient: Administering albumin solely to correct laboratory values without addressing underlying causes 3
  • Ignoring inflammation: Acute or chronic inflammation limits the specificity of serum albumin as a nutritional marker 1
  • Overlooking nutritional status: Hypoalbuminemia may reflect inadequate protein and caloric intake requiring nutritional intervention rather than albumin infusion 3
  • Disregarding clinical context: Patient's clinical status (comorbid conditions, dialysis modality, acid-base status, degree of proteinuria) must be examined when evaluating serum albumin levels 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Albumin: a comprehensive review and practical guideline for clinical use.

European journal of clinical pharmacology, 2024

Research

Slipping Through the Pores: Hypoalbuminemia and Albumin Loss During Hemodialysis.

International journal of nephrology and renovascular disease, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.